-
VER 155008: HSP 70 Inhibitor Workflows
2026-08-13
VER 155008 connects biochemical measurement of Hsp70 ATPase activity with cell-based studies of apoptosis and cancer cell proliferation inhibition. This guide shows how to control solvent effects, separate cytostasis from cell death, and extend chaperone biology into a carefully bounded TDP-43 condensate model.
-
HyperScript™ RT SuperMix for qPCR: 5 Lab Scenarios
2026-08-13
This scenario-driven guide explains how HyperScript™ RT SuperMix for qPCR, SKU K1074, can support reproducible cDNA synthesis for viability, proliferation, cytotoxicity, and cancer-stemness studies. It connects formulation features with practical decisions involving low-input RNA, complex templates, qRT-PCR controls, interpretation, and vendor selection.
-
X-press Tag Peptide in RHEB Signaling Research
2026-08-12
A translational perspective on using X-press Tag Peptide as an N-terminal leader peptide to connect recombinant protein purification, orthogonal detection, and mechanistic studies of the UBE2F–SAG–RHEB–mTORC1 axis.
-
3D Organoid–Fibroblast Models of PDAC Chemoresistance
2026-08-12
Schuth and colleagues developed a patient-specific three-dimensional co-culture system that combines pancreatic ductal adenocarcinoma organoids with matched cancer-associated fibroblasts. The model revealed increased tumor-cell proliferation, reduced chemotherapy-induced death, and stromal induction of inflammatory and epithelial-to-mesenchymal transition programs, showing why epithelial-only organoids can underestimate microenvironment-mediated drug resistance.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-08-11
Montes-Worboys and colleagues developed a dendritic-cell delivery strategy to direct fluorescently labeled amikacin into Mycobacterium avium granulomas in infected mice. The study provides proof-of-concept for localized aminoglycoside delivery, while also showing that the modified drug retained comparable antimycobacterial activity and did not produce the measured inflammatory signal.
-
Cycloastragenol Protects Against GIONFH in Rats
2026-08-11
This in vivo study shows that cycloastragenol limits methylprednisolone-associated femoral-head damage in rats by suppressing osteoclast activity, preserving trabecular bone, and improving local blood supply. Its value is mechanistic as well as therapeutic: the findings position the RANKL/OPG axis and osteoclast-resorption program as measurable targets for hip-preservation research, while still requiring validation beyond the animal model.
-
TH287 Radiosensitizes Castration-Resistant Prostate Cancer
2026-08-10
The reference study shows that TH287 can enhance ionizing-radiation responses in PC-3 and DU-145 castration-resistant prostate cancer cells, with the strongest effect when radiation follows initial inhibitor exposure by 12 hours. Its main innovation is the treatment-schedule analysis, supported by survival, apoptosis, protein-expression, and cell-cycle measurements.
-
Sulfo-NHS-SS-Biotin for AML Surface Mapping
2026-08-09
Sulfo-NHS-SS-Biotin enables reversible surface-amine labeling that can complement emerging AML target-discovery workflows. This article explains how its cleavable chemistry can distinguish accessible cell-surface biology from intracellular abundance, using recent csNPM1 findings to guide assay design.
-
Pitavastatin (NK-104): In Vitro Workflow Guide
2026-08-08
Pitavastatin (NK-104) provides a practical way to inhibit HMG-CoA reductase and study cholesterol biosynthesis in cellular or biochemical assays. This dossier-based guide covers preparation, controls, QC, and interpretation limits; the compound is not validated here for clinical treatment or in vivo animal workflows.
-
Annexin V, human recombinant: Assay Guide
2026-08-07
Learn how Annexin V, human recombinant (SKU K2064) can strengthen apoptosis and cytotoxicity workflows by measuring phosphatidylserine externalization alongside metabolic or viability endpoints. This scenario-based guide covers assay design, calcium-dependent binding, interpretation, optimization, and practical reagent selection.
-
Dlin-MC3-DMA: Ionizable Cationic Liposome Transforming RNA D
2026-08-07
Dlin-MC3-DMA’s ionizable cationic liposome chemistry is redefining RNA therapeutics, delivering unmatched potency for both siRNA and mRNA workflows. Its integration with machine learning-driven LNP design is accelerating breakthroughs in gene silencing and immunomodulation, especially for challenging cell types like microglia.
-
GPR35-KLF5 Circuitry Regulates Epithelial Repair in DSS Coli
2026-08-06
This study uncovers a tryptophan metabolic gatekeeping mechanism in which GPR35 senses mucosal damage and activates KLF5-dependent programming for epithelial repair. The findings clarify how intestinal epithelial cells decode injury signals, offering mechanistic insight for advancing ulcerative colitis research using DSS-induced mouse models.
-
S Tag Peptide: Practical Use for Solubility and Detection
2026-08-06
S Tag Peptide addresses common recombinant protein workflow challenges by enhancing solubility and enabling antibody-based detection. It is best suited for applications requiring robust purification and detection, but is unsuitable where ethanol solubility or independent enzymatic activity is needed.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibitor Workf
2026-08-05
EPI-001 offers researchers a powerful tool to inhibit androgen receptor activity at the N-terminal domain, enabling targeted investigation of resistant prostate and triple-negative breast cancer models. This guide translates recent findings into actionable protocols, troubleshooting tactics, and advanced applications, driving more robust outcomes in AR-driven oncology research.
-
Nav1.5 Ser571 Phosphorylation Drives Age-Related Cardiac Dys
2026-08-05
This study reveals that phosphorylation of the cardiac sodium channel Nav1.5 at Ser571 increases late sodium current (INa,L), triggering delayed ventricular repolarization and diastolic dysfunction in aging hearts. The findings provide a mechanistic link between molecular ion channel modifications and age-associated cardiac myopathy, highlighting late sodium current inhibition as a focused target for arrhythmia prevention research.